Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease
Clinical trial NCT03010332 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03010332
- Sponsor
- Atara Biotherapeutics
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.